Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.02)
# 2,940
Out of 4,884 analysts
474
Total ratings
38.22%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Upgrades: Buy | $3 | $1.91 | +57.07% | 13 | Jun 30, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $110 → $130 | $80.48 | +61.53% | 4 | Jun 24, 2025 | |
| OCGN Ocugen | Reiterates: Buy | $7 | $0.96 | +631.45% | 22 | Jun 24, 2025 | |
| ELEV Elevation Oncology | Downgrades: Neutral | $1 → $0.36 | $0.39 | -7.22% | 10 | Jun 10, 2025 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $33 → $35 | $14.45 | +142.21% | 8 | May 29, 2025 | |
| UNCY Unicycive Therapeutics | Assumes: Buy | $90 | $4.60 | +1,856.52% | 1 | May 27, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $24 → $29 | $12.69 | +128.53% | 13 | May 23, 2025 | |
| MDWD MediWound | Maintains: Buy | $25 → $31 | $19.34 | +60.29% | 19 | May 22, 2025 | |
| MIRM Mirum Pharmaceuticals | Assumes: Buy | $73 | $50.30 | +45.13% | 1 | May 19, 2025 | |
| CELC Celcuity | Reiterates: Buy | $27 | $13.79 | +95.79% | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $2.14 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.10 | +354.55% | 9 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.36 | +120.59% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $2.28 | +75.44% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.18 | - | 12 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $18.85 | +112.20% | 6 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.46 | +334.69% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $9 | $7.45 | +20.81% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $72.27 | +100.64% | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $3.28 | +1,729.27% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $7 | $1.89 | +270.37% | 16 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 → $11 | $1.88 | +486.67% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.31 | +281.68% | 11 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.39 | +485.77% | 12 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.68 | +30.60% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.59 | +1,094.97% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.29 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.62 | +270.37% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.77 | +152.71% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $6.59 | +203.49% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.18 | +8,156.88% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $6.11 | +309.17% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.67 | +1,840.30% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.45 | +186.30% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $41.74 | +43.75% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.43 | +344.15% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.38 | +694.86% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.30 | +1,594.34% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.85 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.34 | +73.50% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.61 | +1,142.24% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.03 | +78.93% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.00 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.77 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.32 | +581.82% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.98 | +1,162.63% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.85 | +170.27% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $4.80 | +2,400.00% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.30 | +823.08% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.38 | +5,217.73% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.30 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $1.23 | +6,404.07% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $3.95 | +51.90% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $2.53 | +492.89% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $4.80 | +587.50% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $10.99 | -13.56% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $2.03 | +689,555.17% | 1 | Mar 5, 2020 | |
Vor Biopharma
Jun 30, 2025
Upgrades: Buy
Price Target: $3
Current: $1.91
Upside: +57.07%
Nuvalent
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $80.48
Upside: +61.53%
Ocugen
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $0.96
Upside: +631.45%
Elevation Oncology
Jun 10, 2025
Downgrades: Neutral
Price Target: $1 → $0.36
Current: $0.39
Upside: -7.22%
Eton Pharmaceuticals
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $14.45
Upside: +142.21%
Unicycive Therapeutics
May 27, 2025
Assumes: Buy
Price Target: $90
Current: $4.60
Upside: +1,856.52%
Delcath Systems
May 23, 2025
Maintains: Buy
Price Target: $24 → $29
Current: $12.69
Upside: +128.53%
MediWound
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $19.34
Upside: +60.29%
Mirum Pharmaceuticals
May 19, 2025
Assumes: Buy
Price Target: $73
Current: $50.30
Upside: +45.13%
Celcuity
May 19, 2025
Reiterates: Buy
Price Target: $27
Current: $13.79
Upside: +95.79%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $2.14
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.10
Upside: +354.55%
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.36
Upside: +120.59%
May 14, 2025
Assumes: Buy
Price Target: $4
Current: $2.28
Upside: +75.44%
May 14, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.18
Upside: -
May 13, 2025
Reiterates: Buy
Price Target: $40
Current: $18.85
Upside: +112.20%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.46
Upside: +334.69%
May 7, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $7.45
Upside: +20.81%
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $72.27
Upside: +100.64%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $3.28
Upside: +1,729.27%
May 2, 2025
Maintains: Buy
Price Target: $1.5 → $7
Current: $1.89
Upside: +270.37%
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $1.88
Upside: +486.67%
Apr 11, 2025
Reiterates: Buy
Price Target: $5
Current: $1.31
Upside: +281.68%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $2.39
Upside: +485.77%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.68
Upside: +30.60%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.59
Upside: +1,094.97%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.29
Upside: -
Mar 20, 2025
Reiterates: Buy
Price Target: $6
Current: $1.62
Upside: +270.37%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.77
Upside: +152.71%
Mar 17, 2025
Initiates: Buy
Price Target: $20
Current: $6.59
Upside: +203.49%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.18
Upside: +8,156.88%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $6.11
Upside: +309.17%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.67
Upside: +1,840.30%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $24.45
Upside: +186.30%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $41.74
Upside: +43.75%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $7.43
Upside: +344.15%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $1.38
Upside: +694.86%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.30
Upside: +1,594.34%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.85
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $6.34
Upside: +73.50%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $1.61
Upside: +1,142.24%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.03
Upside: +78.93%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.00
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.77
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.32
Upside: +581.82%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.98
Upside: +1,162.63%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.85
Upside: +170.27%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $4.80
Upside: +2,400.00%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.30
Upside: +823.08%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.38
Upside: +5,217.73%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $15.30
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $1.23
Upside: +6,404.07%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $3.95
Upside: +51.90%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $2.53
Upside: +492.89%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $4.80
Upside: +587.50%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $10.99
Upside: -13.56%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $2.03
Upside: +689,555.17%